Accendra Health, Inc. shareholders at the 2026 Annual Meeting elected six directors, ratified KPMG LLP as auditors, approved executive compensation on an advisory basis, and approved the Amended and Restated 2023 Omnibus Incentive Plan.
Key takeaways
Shareholders elected Mark A. Beck, Gwendolyn M. Bingham, Kenneth Gardner-Smith, Stephen W. Klemash, Teresa L. Kline, and Edward A. Pesicka as directors for one-year terms.
KPMG LLP ratified as independent auditors for fiscal year ending December 31, 2026 with 61.3M votes for.
Advisory vote approved named executive officer compensation with 48.1M votes for.
Amended and Restated 2023 Omnibus Incentive Plan approved with 50.6M votes for, authorizing equity grants to employees, directors, and consultants.
81.29% of 76.4M entitled shares participated in the meeting.